Frederick C. Beddingfield
Gründer bei SIENNA BIOPHARMACEUTICALS, INC.
Profil
Frederick C.
Beddingfield is the founder of Sienna Biopharmaceuticals, Inc. founded in 2010, where he holds the title of President, Chief Executive Officer & Director.
Currently, he is the Chief Executive Officer at Kira Pharmaceuticals (US) LLC since 2020, a Director at Cytrellis Biosystems, Inc. since 2015, and a Director-Camp Wonder at Children's Skin Disease Foundation.
He is also a Clinical Associate Professor at David Geffen School of Medicine since 2003.
Previously, he worked as Vice President, Global Head-Dermatology, R&D at Allergan, Inc. in 2013 and as Chief Medical Officer at Kythera Biopharmaceuticals LLC from 2013 to 2015.
He completed his undergraduate degree at North Carolina State University and holds a doctorate from Frederick S.
Pardee RAND Graduate School and The University of North Carolina at Charlotte.
Aktive Positionen von Frederick C. Beddingfield
| Unternehmen | Position | Beginn |
|---|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Gründer | 27.06.2010 |
Cytrellis Biosystems, Inc.
 Cytrellis Biosystems, Inc. Medical SpecialtiesHealth Technology Cytrellis Biosystems, Inc. designs and develops aesthetic devices. The company was founded by William Gerald Austen and Doug A. Levinson and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 01.07.2015 |
| Children's Skin Disease Foundation | Corporate Officer/Principal | - |
| David Geffen School of Medicine | Corporate Officer/Principal | 01.01.2003 |
Kira Pharmaceuticals (US) LLC
 Kira Pharmaceuticals (US) LLC Pharmaceuticals: MajorHealth Technology Part of Kira Pharmaceuticals (Suzhou) Co., Ltd., Kira Pharmaceuticals (US) LLC develops transformative therapies for people with complement-mediated diseases. The company is based in Cambridge, MA. The company was founded by Gonghua Pan, Wenru Song. Frederick C. Beddingfield has been the CEO of the company since 2020. | Vorstandsvorsitzender | 01.05.2020 |
Ehemalige bekannte Positionen von Frederick C. Beddingfield
| Unternehmen | Position | Ende |
|---|---|---|
| KYTHERA BIOPHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2015 |
| ALLERGAN, INC. | Corporate Officer/Principal | - |
Ausbildung von Frederick C. Beddingfield
| North Carolina State University | Undergraduate Degree |
| Frederick S. Pardee RAND Graduate School | Doctorate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Cytrellis Biosystems, Inc.
Cytrellis Biosystems, Inc. Medical SpecialtiesHealth Technology Cytrellis Biosystems, Inc. designs and develops aesthetic devices. The company was founded by William Gerald Austen and Doug A. Levinson and is headquartered in Boston, MA. | Health Technology |
| Children's Skin Disease Foundation | |
Kira Pharmaceuticals (US) LLC
Kira Pharmaceuticals (US) LLC Pharmaceuticals: MajorHealth Technology Part of Kira Pharmaceuticals (Suzhou) Co., Ltd., Kira Pharmaceuticals (US) LLC develops transformative therapies for people with complement-mediated diseases. The company is based in Cambridge, MA. The company was founded by Gonghua Pan, Wenru Song. Frederick C. Beddingfield has been the CEO of the company since 2020. | Health Technology |
